Hisamitsu Pharmaceutical Co AAQS 2024
Hisamitsu Pharmaceutical Co AAQS
5
Ticker
4530.T
ISIN
JP3784600003
WKN
864341
Hisamitsu Pharmaceutical Co has a current AAQS of 5.
A high AAQS can be seen as a positive indicator that the company is developing successfully.
Investors can assume that the company is on a good path to generate profits.
On the other hand, it is important to consider the AAQS of the stock Hisamitsu Pharmaceutical Co in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.
In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.
Hisamitsu Pharmaceutical Co Aktienanalyse
What does Hisamitsu Pharmaceutical Co do?
Hisamitsu Pharmaceutical Co Inc is a Japanese company that was founded in 1847. The company is known for its patches and other medical products, making it one of the largest pharmaceutical manufacturers in Japan. The company specializes in the development and production of pharmaceuticals, medical devices, and health and beauty products. They have four main business areas: pharmaceutical products, health products, medical devices, and cosmetics. In addition to their popular Salonpas patches, they also offer a range of other medications, health products, medical devices, and cosmetics. Hisamitsu is committed to improving health and well-being through innovation and collaboration with research institutions and universities. Hisamitsu Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Frequently Asked Questions about Hisamitsu Pharmaceutical Co stock
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Hisamitsu Pharmaceutical Co
Our stock analysis for Hisamitsu Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hisamitsu Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Hisamitsu Pharmaceutical Co Revenue
- Hisamitsu Pharmaceutical Co Net Income
- Hisamitsu Pharmaceutical Co P/E
- Hisamitsu Pharmaceutical Co P/S
- Hisamitsu Pharmaceutical Co EBIT
- Hisamitsu Pharmaceutical Co Dividend
- Hisamitsu Pharmaceutical Co Stocks
- Hisamitsu Pharmaceutical Co Market capitalization
- Hisamitsu Pharmaceutical Co Debt
- Hisamitsu Pharmaceutical Co Liabilities
- Hisamitsu Pharmaceutical Co Equity
- Hisamitsu Pharmaceutical Co AAQS
- Hisamitsu Pharmaceutical Co Employees
- Hisamitsu Pharmaceutical Co ROE
- Hisamitsu Pharmaceutical Co ROA
- Hisamitsu Pharmaceutical Co ROCE